Previous work by us as well as others, mainly in cell lines of leukemia, colon and pancreatic cancers, indicate that these compounds could affect the NF-κB pathway [15,16,17] and that reactive oxygen species (ROS) production contributed to the suppression of NF-κB activity in leukemic cells [17]. The gene discussed is NFKB1; the disease is pancreatic neoplasm.